PAT growth masks revenue stagnation; execution risk on capex timelines

Delivered ₹231.9 Cr revenue, +9.8% YoY. Management rounded up slightly but accurate.

Delivered QoQ decline -8.9%, management's 255→232 reflects exact same -8.9%

Calculated EBITDA from P&L (PBT+Finance+Depreciation ≈ 7 Cr); 7/232 = 3% margin. Matches.

Delivered PAT ₹3.7 Cr, claimed ₹3 Cr (management used lower figure, likely rounding). PAT growth +119% QoQ (1.7→3.7) is exceptional.

Stated as subset of ₹232 Cr total; leaves ~₹162 Cr trading. Export drop from 60-70% to 45% is unequivocal — due to export duties post-budget.

Management stated ₹15-20 Cr done on ₹45 Cr Dewas capex, remainder in H2. Timeline: 'mid of next year' but explicitly hedged ('can't commit, dates always go ahead').

Manufacturing export share: 60-70% (FY26 baseline) → 45% (Q1 FY27) due to export duties post-Aug 2024 budget. Management pivoting to domestic value-add but conversion slow.

Dewas plant originally vague; now explicitly 'mid-FY28' but hedged ('can't commit, dates in India always go ahead'). Only ₹15-20 Cr of ₹45 Cr capex done; H2 major spend anticipated.

Italian press expected 3-year ramp (35%/50%/75%); Q1 FY27 is 18+ months post-commissioning but only 25% ramp achieved. Significant catch-up required.

Management holding 'flattish' guidance for FY27 manufacturing revenue. No numeric FY27/FY28 target disclosed. Ramp-up timing vague ('towards end of FY27 or early FY28').

Manufacturing production ~1,558 metric tons. EBITDA per ton not disclosed on blended basis; numbers not readily available.

Market has been sluggish post-export duties, which impacted exports from 60-70% to 45%. Trying to realign to domestic high-value business, which is taking time. Ramp-up maybe towards end of year or early next year.

95%+ hedged (only <5% unhedged). Charge absolute EBITDA per ton. Commodity impact <5%. Extrusion margins 6-10%, value-add margins 15%+. Anodizing 45-50% utilized, machining 55%. Scope for margin accretion as utilization ramps.

₹15-20 Cr done of ₹45 Cr total. Own capacity coming online in 6-8 months [implied by mid-FY28]. Aerospace/defense/auto segment, precision tubing, very high margins but low volume. Asset turn 2-3x at peak. Margin numbers TBD ('not at this point of time').

Expected 3-year ramp of 35%, 50%, 75%. Currently at 25% ramp. Much tooling and alloy development in progress. Significant contribution expected by mid next year.

<₹5 Cr capex in Q1. Major capex in H2 FY27. Working capital elongation due to raw-material procurement for capex readiness and customer credit terms — will normalize post-ramp. No debt; deleveraging actually.

Tech team already hired 2 quarters ago for R&D and technical development. No incremental headcount expected even as volumes ramp.

Increased conversion and transferred ~50% of gas cost increase to customers in last 2 quarters. Balance 50% still being negotiated in short/medium-term contracts. Will recover as contracts renew.

Given flattish guidance for year, not able to forecast. If we maintain last year's level, okay with it; obviously want better.

No specific FY27 target. Management cites export-duty headwinds, shipping delays as near-term headwinds. Expected ramp from Pithampur and Dewas ramp-up in H2.

Margin expansion thesis driven by utilization ramp and product-mix shift. Near-term margin pressure from freight/gas costs 50% cost-share with customers; balance 50% recovery via contract renewal.

<₹5 Cr spent Q1; major spending in H2 FY27 and beyond. Indicative; subject to ROI review and business conditions.

Export share of manufacturing fell 60-70% to 45% due to export duties. Domestic value-add ramp-up slow; net revenue growth only 9.8% YoY. If ramp-up underperforms, top-line stalls.

Strait-of-Hormuz disruptions and Middle East geopolitical tensions causing freight costs to multiply 5-10x normal levels. Management transferring only 50% to customers; balance 50% unrecovered. Recovery timing uncertain ('very difficult to give guidance').

Dewas precision-tubing capex (₹45 Cr) originally promised timeline not met; now 'mid-FY28' but explicitly hedged ('can't commit, dates in India always go ahead'). Pithampur ramp-up lagged expected 3-year plan (25% ramp at 18+ months). If Dewas delays further or ROI underperforms, margin recovery stalls.

Q1 EBITDA margin only 3%, NPM 1.6%. Extrusion business is commoditized (6-10% margins). Value-add manufacturing still at 45-55% utilization. If capex ramp-up is slow or new capacity doesn't achieve projected margins, returns will be compressed.

WC days increased FY25 → FY26 due to capex-driven raw-material procurement and customer credit expansion. If not managed tightly, cash consumption could spike.